Stroke survivors and recent surgical patients face an elevated risk of blood clot formation in the lower legs, as decreased mobility diminishes the ability of the body's natural compression system to pump blood out of deep leg veins. Low compliance rates, discomfort, and limited effectiveness detract from external compression, the current standard of clot prevention, leading Sky Medical to meet the market's need with a bioelectronic device that electrically stimulates motor neurons.Subscribe now to read the full analysis
Welcome to MyStrategist, an online experience like no other in the medical device industry.
With MyStrategist, quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and MedTech Strategist Market Pathways – now on an all-in-one, digital platform. We invite you to explore our coverage.
Think Strategically. Subscribe Today.
Registration is now open for the 7th annual Innovation Summit Dublin, April 21-23, 2020. The industry's most anticipated event will sell out. Register Today.Register Learn More
With the new Medical Device Regulation about to be implemented in Europe, senior officials from across the medtech landscape advise how companies and investors can make the best of what one called “the worst thing to happen to European healthcare since World War II.”Subscribe now to read the full analysis
Pathways’ Picks February 5: CMS Eyes Cardiac Devices, Coronavirus Policies, More to Watch
Pathways’ Picks February 12: Budget Roundup, News from Asia, FDA and CMS Updates
Pathways’ Picks February 19: Coronavirus Cancellations, EU Digital, NICE on Neurostim
Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.Learn More
With more than 73,000 cases and 1,870 deaths, the coronavirus outbreak (COVID-19) continues to create disruptions and trigger response activity worldwide. Here, we check in on the most recent medtech implications in this week’s top news pick from Market Pathways.Subscribe now to read the full analysis